TARDBPP1: A Potential Drug Target for Cancer and Neurodegenerative Diseases

Target Name: TARDBPP1

NCBI ID: G643503

TARDBPP1

Other Name(s): TARDBP pseudogene 1 | bA318P23.1 | TARDBPL | TAR DNA binding protein pseudogene 1

TARDBPP1: A Potential Drug Target for Cancer and Neurodegenerative Diseases

TARDBPP1 (TARDBP pseudogene 1) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The TARDBPP1 gene is located on chromosome 12 and encodes a protein known as TARDBP, which is a key regulator of the cell cycle and has been shown to play a role in the development and progression of various diseases.

Studies have shown that TARDBP is overexpressed in a variety of cancer types, including breast, ovarian, and prostate cancer. Additionally, TARDBP has been shown to be overexpressed in neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases, as well as autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis.

Furthermore, overexpression of TARDBP has been shown to promote the growth and survival of cancer cells, and to inhibit the death of cancer cells that have become resistant to chemotherapy.

These findings suggest that TARDBP may be a promising drug target or biomarker for the treatment of cancer and other diseases. Researchers are currently working to develop TARDBP-based therapies, and to determine the underlying mechanisms that regulate its function.

In addition to its potential as a drug target or biomarker, TARDBP also has potential as a biomarker for monitoring disease progression and response to treatment. For example, TARDBP has been shown to be expressed in the blood and urine of patients with cancer, and its levels have been used as a marker for disease progression and response to chemotherapy.

Overall, the TARDBPP1 gene is a promising target for the development of new drugs and therapies for the treatment of cancer and other diseases. Further research is needed to fully understand its function and potential as a drug and biomarker.

Protein Name: TARDBP Pseudogene 1

The "TARDBPP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TARDBPP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets